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List of abbreviations 
5-HT   5-hydroxytryptamine, serotonin 
5-HT2AR  5-hydroxytryptamine 2A receptor 
5-HT2CR  5-hydroxytryptamine 2C receptor 
α-MSH  α-melanocyte-stimulating hormone 
ARC  Arcuate nucleus of the hypothalamus 
CEL  Cell intensity files 
E16.5   Embryonic day 16.5 
FFT  Free fraction of tryptophan 
GCOS  GeneChip operating software 
GC-RMA GeneChip robust multi-array averaging 
IUGR  Intra-uterine growth restricted 
ISHH  In situ hybridization histochemistry 
LCM  Laser captured micro dissection 
POMC  Pro-opiomelanocortin 
P3  Postnatal day 3 
RMA  Robust multi-array averaging 
TCB2  [(4-Bromo-3,6-dimethoxybenzocyclobuten-1-yl) methylamine hydrobromide 
VMN  The ventromedial nucleus of the hypothalamus 
 
 
Summary Statement 
Maternal protein restriction increases fetal brain 5-HT and may contribute to changes in expression 
and function of hypothalamic 5-HT2C and 5-HT2A receptors in the offspring later in life. 
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Translational Impact 
Clinical issue: 
As the prevalence of obesity increases across the globe major efforts are directed at studying the 
mechanisms involved. Growing evidence suggests that susceptibility to obesity can be programmed 
by maternal and neonatal nutrition. In particular, individuals with low birth weight that undergo 
rapid postnatal growth are at higher risk of developing increased adiposity in later life. The 
molecular mechanisms mediating the interaction between early nutrition and obesity risk are, 
however, still largely unknown. Currently, there are no pharmacological therapies to prevent the 
increase in adiposity in individuals that underwent nutritional challenge in early life. Serotonin (5-HT) 
system is widely recognized as one of the key regulators of food intake and body weight. During fetal 
life serotonin also acts as a trophic factor that regulates brain development. As compounds targeting 
endogenous serotonin bioavailability have been among the most clinically effective treatments for 
obesity (e.g. d-fenfluramine), treatment targeting serotonin system may prevent the development of 
obesity in at risk individuals. 
 
Results: 
The study has shown that maternal protein restriction increased levels of serotonin in the blood of 
pregnant rat mums and in the placenta and the fetal brain. In adulthood the offspring had a reduced 
ability to sense serotonin, which was associated with a reduced hypothalamic expression of 5-HT2C 
receptors - the primary serotonin receptor influencing appetite. As expected, reduced 5-HT2C 
receptor expression was associated with impaired sensitivity to serotonin-mediated appetite 
suppression and hence could lead to increases in food intake. On the other hand offspring of low 
protein dams had a programmed increase in 5-HT2A receptors, which are positioned, just like 5-HT2C 
receptors, in the arcuate nucleus of the hypothalamus - a key area of the brain, involved in the 
control of food intake. Moreover, these animals were more sensitive to 5-HT2A receptor agonist-
induced appetite suppression. 
 
Implications and future directions: 
This study identified a molecular mechanism that is involved in mediating the effects of suboptimal 
maternal diet on the regulation of food intake in the offspring. In addition, the authors showed that 
a treatment with 5-HT2A receptor agonist may potentially prevent the development of obesity in 
individuals that were exposed in utero to suboptimal nutrition and then underwent rapid postnatal 
growth. Non-hallucinogenic 5-HT2A receptor agonist should be used for such treatment. Combining 
the 5-HT2A receptor agonist with 5-HT2CR and 5-HT1BR agonists could potentially further increase the 
anorectic therapeutic effect. 
  
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
 
Abstract  
Though obesity is a global epidemic, the physiological mechanisms involved are little understood. 
Recent advances reveal that susceptibility to obesity can be programmed by maternal and neonatal 
nutrition. Specifically, a maternal low protein diet during pregnancy causes decreased intrauterine 
growth, rapid postnatal catch-up growth and increased risk for diet-induced obesity. Given that the 
synthesis of the neurotransmitter 5-hydroxytryptamine (5-HT) is nutritionally regulated and 5-HT is a 
trophic factor, we hypothesized that maternal diet influences fetal 5-HT exposure, which then 
influences central appetite network development and the subsequent efficacy of 5-HT to control 
energy balance in later life. Consistent with our hypothesis, pregnant low protein fed rat mothers 
exhibited elevated serum 5-HT, which was also evident in the placenta and fetal brains at E16.5. This 
increase was associated with a reduced hypothalamic expression of the primary 5-HT receptor 
influencing appetite, 5-HT2CR in the fetal brain as well as neonatal and adult hypothalamus. As 
expected, reduced 5-HT2CR expression was associated with impaired sensitivity to 5-HT-mediated 
appetite suppression in adulthood. 5-HT primarily achieves effects on appetite via 5-HT2CR 
stimulation of pro-opiomelanocortin (POMC) peptides within the arcuate nucleus of the 
hypothalamus (ARC). We reveal that 5-HT2ARs are also anatomically positioned to influence the 
activity of ARC POMC and that 5-HT2AR mRNA is increased in the hypothalamus of in utero growth 
restricted offspring that underwent rapid postnatal catch-up growth. Furthermore, these animals at 
3-months of age are more sensitive to 5-HT2AR agonist-induced appetite suppression. These findings 
may not only reveal a 5-HT-mediated mechanism underlying programming of obesity susceptibility 
but also provide a promising means to correct it, via a 5-HT2AR agonist treatment.  
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Introduction  
Nutrition during critical periods of development in early life can exert profound, long-term 
effects on susceptibility to obesity. For example, men exposed to the Dutch Hunger Winter in utero 
during early gestation had an increased risk of developing obesity as adults, while obesity rates were 
reduced amongst those exposed to famine during the last trimester of gestation and in early 
postnatal life (Ravelli et al., 1976). The early postnatal diet is also important. In randomized trials, 
full-term, low birth weight infants fed a growth-promoting nutrient-enriched formula had a higher 
fat mass at the age of 5-8 years than those fed standard formula (Singhal et al., 2010). Studies in 
rodents, showing that low birth weight followed by rapid postnatal growth is associated with 
increased adiposity, support findings in humans (Plagemann et al., 1992; Cottrell et al., 2011; 
Berends et al., 2013). Despite these robust associations, the molecular mechanisms mediating the 
interaction between early nutrition and obesity risk are still largely unknown. 
It is widely acknowledged that the hypothalamus, which in humans develops primarily 
prenatally but in rodents postnatally, plays an important role in the programming of body weight 
(Grove et al., 2005; Horvath and Bruning, 2006; Glavas et al., 2007). To date major efforts have been 
directed at understanding the roles of leptin and insulin in this process (Bouret et al, 2010; Yura et 
al., 2005; Steculorum and Bouret, 2011). However, studies in our laboratory using the leptin-
deficient ob/ob mice demonstrated that leptin-independent mechanisms are likely to also program 
body weight (Cottrell et al., 2011).  
The importance of the 5-hydroxytryptamine (5-HT; serotonin) system in the control of food 
intake and body weight has been recognised for many years and alterations in central serotonergic 
activity have been observed in obese humans, non-human primates and rodents (Mori et al., 1999; 
De Fanti et al., 2001; Sullivan et al., 2010). 5-HT, a potent anorectic signal, influences food intake in 
the mature brain by acting predominantly via 5-HT2CR to regulate the key energy balance mediator, 
pro-opiomelanocortin (POMC), within the arcuate nucleus of the hypothalamus (ARC) (Doslikova et 
al., 2013; Burke et al., 2014).  Indeed, genetic disruption of the 5-HT2CR specifically expressed on 
POMC neurons programs hyperphagia and obesity when animals are fed a high-fat diet (Berglund et 
al., 2013). In addition to playing an important role in energy balance and body weight, 5-HT acts as a 
trophic factor during fetal brain development in rodents, regulating cell migration, proliferation, 
maturation and axonal growth (Whitaker-Azmitia et al., 1996; Gaspar et al., 2003). The long term 
effects of disturbances in the 5-HT system during early life on obesity risk are, however, not fully 
defined.  
Here we investigated 5-HT system function and used an unbiased genome-wide profiling 
approach to identify differentially expressed targets in the hypothalamus of intrauterine-restricted 
rats that underwent postnatal catch-up growth (recuperated animals) in an effort to elucidate the 
molecular mechanisms mediating the effects of early nutrition on energy balance.  
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Results  
Growth trajectories, body weights and brain weights 
At birth, offspring of mothers fed a low protein diet during pregnancy were significantly 
smaller than the control pups (P<0.001) (Table 1A). The body weight of the recuperated pups caught 
up with that of control pups by day 14 and they weighed the same as controls at weaning (Table 1A). 
Fractional growth rate did not differ between recuperated and control pups between birth and day 7 
of life (0.16 ± 0.1 vs 0.17 ± 0.01); however recuperated offspring had significantly higher fractional 
growth rate between birth and days 14 and 21 when compared to controls (day 14: 0.31 ± 0.01 vs 
0.24 ± 0.01, P<0.001; day 21: 0.38 ± 0.01 vs 0.29 ± 0.01, P<0.001). At 3 months of age body weights 
were similar between recuperated and control offspring. Brain weights were similar between the 
experimental animals and their age-matched controls at both 22 days and 3 months of age, in both 
absolute terms and relative to body weight (Table 1B). These findings demonstrate that maternal 
low protein diet decreases in utero growth of the offspring so that they have a lower birth weight. 
These animals then undergo “catch up” growth such that by 22 days of age, they are the same body 
weight as the control offspring.  
 
Maternal and offspring 5-HT and tryptophan levels  
Maternal, placental and amniotic fluid 5-HT and tryptophan levels 
Tryptophan is an essential amino acid and is required for 5-HT synthesis. A low protein diet 
would therefore be expected to yield low plasma tryptophan levels. We analyzed the levels of 5-HT 
and tryptophan in the dams, placenta and amniotic fluid to investigate whether 5-HT may be a 
programming factor that mediates changes in appetite and susceptibility to diet-induced obesity in 
recuperated animals. As expected, we observed reduced levels of tryptophan in the serum of low 
protein fed dams at E16.5 of pregnancy compared to control dams (158 ± 17 mmol.l-1 vs 220 ± 20 
mmol.l-1, P<0.05). Paradoxically, the serum 5-HT level was raised in low protein diet fed dams at this 
time-point (P<0.05; Figure 1A). A similar pattern was observed for tryptophan and 5-HT 
concentration in in the amniotic fluid at E16.5, with tryptophan levels being reduced in the amniotic 
fluid from low protein pregnancies (26.3 ± 3.2 mmol.l-1 vs 40.6 ± 3.4 mmol.l-1, P<0.01, n=10-11 per 
group), whilst 5-HT levels were raised (65.0 ± 6.6 nmol.l-1 vs 48.2 ± 3.9 nmol.l-1, P<0.05, n=10-11 per 
group). 5-HT levels were also significantly increased in E16.5 placentas from low protein pregnancies 
when compared to control pregnancies (P<0.01; Figure 1A). Furthermore, we observed a negative 
correlation between placental 5-HT level and maternal serum tryptophan (P<0.05; Figure 1B). There 
was a positive correlation between placental 5-HT and fetal brain 5-HT levels (Figure 1C). These 
findings reveal that in response to significantly reduced dietary tryptophan, 5-HT is over-produced in 
the mother and in the intrauterine environment in which the fetus grows and develops. 
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Fetal, Neonatal, Weaning and Adult tryptophan and 5-HT levels 
Likewise, in the neonatal brain, a decrease in tryptophan levels (67.9 ± 13.6 mmol.l-1 vs 140 ± 
14.7 mmol.l-1, P<0.01) was associated with an increase in 5-HT levels in the hypothalami of 
recuperated pups at birth (P<0.01; Figure 1A). 5-HT levels were also increased in the brains of E16.5 
fetuses from low protein pregnancies (Figure 1A). By weaning as well as at 3-months of age, 
hypothalamic 5-HT levels were normalized to control levels (P21: Recuperated 1347 ± 110 mmol.l-1 
vs Control 1659 ± 131 pmol.g-1 n= 12 per group; 3 months of age: Recuperated 1414 ± 154 mmol.l-1 
vs Control 1354 ± 85 pmol.g-1 n= 10 per group). These data indicate that the over-production of 5-HT 
in response to maternal low protein diet is normalized by weaning. 
 
Effect of D-fenfluramine on food intake 
We next assessed the significance of maternal diet-stimulated increased 5-HT during early 
development on the function of the adult 5-HT system. D-fenfluramine is a pharmacological probe of 
the endogenous 5-HT system that works by stimulating endogenous 5-HT release and blocking its 
reuptake. D-fenfluramine was prescribed until the 1990s for human obesity treatment since 
increasing endogenous 5-HT bioavailability reduces appetite and body weight (Lam et al., 2010; 
Marston et al., 2011). We administered D-fenfluramine into the third ventricle of rats at 3 months of 
age and observed the expected reduction in food intake in controls (Figure 2). However, recuperated 
offspring had impaired sensitivity to 5-HT-stimulated (D-fenfluramine) food intake reduction 
(P<0.05) (Figure 2). These results show that a low protein maternal diet followed by accelerated 
postnatal growth diminishes 5-HT mediated control of food intake in the adult offspring. Given the 
strong inverse correlation between 5-HT and appetite, these findings lead us to hypothesise that 
deregulated 5-HT system may contribute to the programmed increased food intake in these 
offspring when exposed to an obesogenic diet.   
 
Fetal, neonatal and postnatal hypothalamic 5-HT2CR expression 
5-HT is a neurotransmitter that communicates appetite-related signals primarily through the 
5-HT2CR within the ARC.  If 5-HT’s effects on appetite are diminished in recuperated rats, this 
suggests a perturbation in signalling at the 5-HT2CR. We next probed the consequence of elevated 5-
HT during development on the expression of the 5-HT2CR. Analysis of E16.5 fetal brain 5-HT2CR mRNA 
expression showed significantly reduced 5-HT2CR in the whole heads of fetuses from low protein 
pregnancies (P<0.05; Figure 3A). At birth 5-HT2CR was still reduced in the hypothalamus of the 
growth restricted pups at the mRNA (P<0.001; Figure 3A) as well as at the protein (P<0.001; Figure 
3B,C) level. However, by 3 months of age no significant differences in 5-HT2CR mRNA levels were 
observed between the experimental groups (Figure 3A). Protein expression was, however, still 
significantly reduced in the hypothalamus of recuperated animals at 3-months of age (P<0.05; Figure 
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3B,C). Given that perturbations of ARC 5-HT2CR function increases appetite and body weight 
(Berglund et al., 2013), these results thereby reveal a potential mechanism through which rapid 
postnatal growth is achieved in recuperated rats, which also could potentially contribute to 
increased susceptibility to diet-induced obesity in these animals.  
 
 Microarray analysis of LCM ARC from control and recuperated 3-month-old offspring        
5-HT is a trophic factor during fetal brain development influencing both 5-HT circuits and the 
anatomical organisation of other systems (Whitaker-Azmitia et al., 1996; Gaspar et al., 2003). The 
ARC is a crucial regulator of energy balance. Having demonstrated that maternal diet induces 
changes in offspring 5-HT and disrupts 5-HT appetite system function, we next probed whether 5-HT 
disrupts other ARC genes and circuits regulating appetite. To achieve this, we performed LCM of the 
ARC of 3-month-old control and recuperated rats and subjected samples to microarray. 
 
Validation of laser-capture micro dissection (LCM) 
To ensure the specificity of the ARC dissection within the LCM material (Figure 4), we 
analyzed the expression of two genes that are not expressed in the ARC but are expressed in the 
neighbouring hypothalamic nuclei. Neither PVN-specific Brn1 (Pou3f3) nor the ventromedial nucleus 
of the hypothalamus (VMN) specific Sf-1 were detected (data not shown). In addition, we examined 
the expression of four key genes involved in the regulation of energy balance in the ARC: POMC, 
AgRP, CART and NPY. We confirmed using Taqman RT-PCR that all of these genes were highly 
expressed in the dissected material (data not shown). 
 
Analysis of microarrays using three different algorithms and pathway analysis 
Following global transcriptional profiling, we analyzed the data using three different 
algorithms (1) GeneChip Operating Software (GCOS), (2) Robust Multi-array Averaging (RMA) and (3) 
GeneChip Robust Multi-array Averaging (GCRMA) to ensure maximum stringency and to reduce the 
number of false positives. The combined analysis, using a 1.3- fold cut off threshold and P<0.05, 
revealed that out of 31,099 genes analyzed, expression of 15951 genes was detected in the ARC.  Of 
these 142 genes were up-regulated in the ARC of the recuperated animals, while 59 genes were 
down-regulated (Figure 4A and 4B respectively). The top 25 up- and down-regulated genes in 
recuperated offspring are presented in Tables 2A and 2B. Htr2a, which codes for 5-HT2AR, was the 
gene with the highest (2.55-fold) increase. We further analyzed the microarray data using Ingenuity 
Pathway Analysis software to detect groups of functionally-related genes. The top three gene 
functions affected by early nutrition in 3-month-old male recuperated rats were cell cycle, 
connective tissue development and function, cellular growth and proliferation (Table 2C).  
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Validation of genes identified by microarray 
Out of the seven genes chosen for validation, two genes had very low expression (Plau and 
Pde4a). Out of five genes remaining, differential expression of three genes (5-HT2AR, Khsrp and 
Retsat) was confirmed by RT-PCR, whilst two genes were not validated (Car8 and EEF2k) (Figure 5A). 
As the 5-HT2AR had the highest fold change in the microarray analysis (Table 2A), it was further 
investigated. The up-regulation of the 5-HT2AR in the ARC of 3-month-old recuperated animals 
(P<0.05) observed using RT-PCR was confirmed by in situ hybridization (P<0.05; Figure 5B).  
 
Timing and location of increased hypothalamic 5-HT2AR expression  
A similar pattern of 5-HT2AR expression to that seen in 3-month-old animals was observed at 
the age of 22 days. 5-HT2AR was significantly elevated in the ARC of recuperated rats at weaning 
(P<0.05; Figure 5C). The expression of 5-HT2AR was, however, not altered in neonatal ARC (Figure 5C) 
or in E16.5 fetal brains (Low protein 0.933+0.035; Control 1.002+0.022). As in the ARC the expression 
of 5-HT2AR was also significantly increased in VMN of 3-month-old recuperated animals (P<0.05; 
Figure 5 D,E). However, in contrast to the ARC, no difference was seen in the 5-HT2AR expression 
within VMN between the two experimental groups at day 22 of life (Figure 5E) suggesting that up-
regulation of 5-HT2AR within the VMN in the recuperated group is secondary to the up-regulation of 
this receptor in the ARC. Overall these findings reveal a change in 5-HT2AR receptor expression using 
an unbiased genome-wide profiling approach and thereby support the importance of maternal diet 
induced changes in the 5-HT system within the hypothalamus in disrupted offspring energy balance.  
 
Neuronal co-localization of ARC 5-HT2AR and POMC 
Within the ARC, 5-HT primarily influences energy balance via action at 5-HT2CR stimulating 
the activity of POMC neurons (Heisler et al., 2002; Xu et al., 2008; Berglund et al., 2013; Burke et al., 
2014). Given that 5-HT2CR expression is reduced in rats exposed to a maternal low protein diet, we 
hypothesized that 5-HT2AR may therefore be up-regulated to compensate for this in an effort to 
normalise energy balance. To determine whether 5-HT2ARs are anatomically positioned to influence 
the activity of POMC neurons, we visualized co-expression using dual histochemical labelling. We 
determined that approximately 40% of the ARC POMC neurons express 5-HT2ARs in control rats 
(Figure 5F). These data reveal a defined population of neurons within the ARC critically involved in 
body weight regulation that could be influenced by Gq-protein coupled 5-HT2ARs.  
 
Effect of 5-HT2AR agonism on food intake 
To assess the functional implications of upregulated ARC 5-HT2AR expression, we 
administered the selective 5-HT2AR agonist TCB2 [(4-Bromo-3,6-dimethoxybenzocyclobuten-1-yl) 
methylamine hydrobromide] directly into the third ventricle and measured its effects on food intake 
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in adult 3-month-old recuperated and control offspring. We confirmed previous results showing that 
5-HT2AR agonism significantly suppresses food intake (Fox et al., 2010). TCB2 also significantly 
decreased food intake in the recuperated offspring as shown by two-way ANOVA analysis (overall 
effect of TCB2 administration, P<0.001; Figure 6). However, the dose response curves between the 
control and recuperated groups were significantly different (P<0.05; Figure 6). Recuperated offspring 
were more sensitive than the controls to the centrally administered action of 5-HT2AR agonist TCB-2 
(overall effect of early nutrition, P<0.05; Figure 6). These results reveal that over-expressed 5-HT2ARs 
in recuperated rats are functional and when pharmacologically stimulated, a greater net effect on 
appetite is achieved.  Extrapolating these findings to endogenous 5-HT activity, as indicated by the 
D-fenfluramine results, suggests that the up-regulation of 5-HT2AR is insufficient to compensate for 
5-HT2CR down-regulation in the 5-HT regulation of appetite.    
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4. Discussion  
Evidence from epidemiological studies and animal models shows that suboptimal early 
nutrition affects susceptibility to obesity in later life. We and others have shown that rodents 
exposed to maternal protein restriction in utero and accelerated postnatal growth (recuperated 
offspring) are more susceptible to development of diet-induced obesity (Ozanne et al., 2004; Bieswal 
et al., 2006). In the current study we focused on 3-month-old recuperated rats fed a chow diet that 
are a similar weight to control offspring. This enabled us to investigate mechanisms mediating the 
effects of early nutrition on susceptibility to developing diet-induced obesity without the 
confounding effects of obesity itself. In recent years, leptin has been studied as a key factor involved 
in programming of obesity risk (Cripps et al., 2009; Bouret, 2004). However, we previously showed 
that programming of increased adiposity is, at least in part, leptin-independent (Cottrell et al., 2011). 
In the current study, we investigated the effect of a maternal low protein diet during gestation on a 
factor directly impacted by reduced dietary protein, 5-HT. We observed that 5-HT levels were 
increased in the fetal brains and neonatal hypothalami of rats exposed to a low protein diet in utero. 
As 5-HT is known as an essential growth and regulatory factor that drives the development and 
maturation of its own cellular network and related neuronal systems (Pino et al., 2004; Oberlander, 
2012), an excess of 5-HT may lead to impaired interneuron migration and abnormal development of 
the serotonergic system itself and its target regions (Pino et al., 2004; Oberlander, 2012). Here we 
suggest that elevated hypothalamic levels of 5-HT in recuperated animals in early life cause 
developmental and functional alterations that increase susceptibility to obesity later in life.  
We observed reduced maternal circulating tryptophan but increased 5-HT in pregnant dams 
fed a low-protein diet. This could be a consequence of (1) increased carbohydrate content in low-
protein diet, added to balance protein reduction to obtain an isocaloric diet and (2) the dams’ 
increased food intake in both absolute and relative terms (Fernandez-Twinn et al., 2003). Such 
dietary intervention can affect maternal insulin levels. Low-protein dams were shown to be 
hyperinsulinaemic at day 14 of pregnancy (Fernandez-Twinn et al., 2003). As circulating tryptophan 
levels decrease in an insulin-dose dependent manner, increased insulin concentration in these dams 
could contribute to the reduced tryptophan levels (Fernandez-Twinn et al., 2003; Fukagawa et al., 
1987). Another possibility is that the dietary intervention has altered the gastrointestinal 
microbiome of the dam. Diet is the key regulator of both taxa and microbiota production of 
metabolites (Scott et al., 2012). More than 90% of 5-HT in the body is synthesized in the gut and 
microbiota has been shown to play a critical role in regulating host 5-HT biosynthesis and  5-HT 
blood levels (Yano et al., 2015).   
Several mechanisms may be involved in mediating the relationship between reduced maternal 
circulating tryptophan and increased 5-HT in the brains of their unborn offspring. In adult rats food 
deprivation leads to an increase in the concentration of circulating free fraction of tryptophan (FFT), 
the fraction that passes through the blood-brain-barrier (Knott and Curzon., 1972; Perez-Cruet et al., 
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1972). Raised circulating FFT and increases in tryptophan uptake by serotonergic neurons, activity of 
tryptophan-5-hydroxylase and synthesis of 5-HT have also been reported in intra-uterine growth 
restricted (IUGR) rat pups and infants (Kalyanasundaram, 1976; Hernandez et al., 1989; Manjerrez et 
al., 1996; Manjerrez et al., 1998). Up-regulation of FFT in IUGR was attributed to abnormal kinetics 
of tryptophan binding to albumin (Hernandez-Rodriguez et al., 2009). Reduced plasma levels of 
leucine, isoleucine and tyrosine which compete with tryptophan for entry into brain, may also 
contribute to an increase in transport of tryptophan across the blood-brain-barrier in IUGR pups 
(Roux and Jahchan, 1974). 
In recent years, in both mice and humans, the placenta has emerged as an important source 
of 5-HT, that can directly impact on the fetal brain development (Bonnin et al., 2011). In our study 
the impact of maternal LP diet on 5-HT was more pronounced in the placenta and fetal brain than in 
the dam. This supports the proposal that, the placenta is cannibalized in response to maternal food 
deprivation to provide nutrients and substrates for the developing hypothalamus (Broad and 
Keverne, 2011). We observed an association between placental 5-HT and fetal brain 5-HT at E16.5, 
the time-point at which 5-HT fibres can be detected in the hypothalamus and both exogenous and 
endogenous sources of 5-HT contribute to fetal 5-HT synthesis (Aitken and Tork, 1988; Bonnin et al., 
2011). Increased 5-HT production within the placenta may contribute to raised 5-HT levels in fetal 
brains from low protein fed dams. Maternal tryptophan levels have also been reported to influence 
central 5-HT levels in the offspring and maternal peripheral 5-HT proved to be important for 
offspring neurodevelopment  (Bonnin and Levitt., 2011; Cote et al., 2007). This suggests that both 
maternal and placental tryptophan/5-HT metabolism may be an important molecular pathway for 
the fetal programming of the 5-HT system and brain development.  
Changes in 5-HT bioavailability not only impact on hypothalamic circuitry formation during 
development but also have been shown to influence appetite and body weight in the adult (Porto et 
al., 2009; Berg et al., 2013; Madden and Zup 2014).  5-HT primarily regulates energy balance via 
activity at the Gq-coupled receptor, 5-HT2CR. Here we report that elevated fetal 5-HT could 
potentially program decreased hypothalamic 5-HT2CR expression, although direct evidence for this 
relationship remains to be established. The reduction in 5-HT2CR may be an early and permanent 
developmental consequence of central hyperserotonemia. Reduced 5-HT2CR function is known to 
promote increased appetite and obesity. Specifically, genetic inactivation of Htr2c that codes for 5-
HT2CRs, leads to lifelong hyperphagia and elevated body weight in mice fed standard chow diet 
(Tecott et al, 1995), while pharmacological activation of these receptors reduces food intake and 
decreases body weight (Heisler et al., 2002; Halford and Harrold, 2012; Burke et al., 2014). 5-HT2CRs 
are involved in mediating the action of d-fenfluramine, which stimulates the release of 5-HT and 
inhibits the re-uptake of 5-HT into nerve terminals (Vickers et al., 2001; Trifunovic and Reilly, 2006; 
Xu et al., 2010). Moreover, the subpopulation of 5-HT2CR expressed solely with POMC is sufficient to 
mediate D-fenfluramine and 5-HT2CR agonist mCPP appetite suppression (Xu et al., 2008). Following 
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the administration of D-fenfluramine into the third ventricle we observed impaired sensitivity to 5-
HT-stimulated food reduction in 3-month-old recuperated animals. As the functional capacity of 5-
HT2CR is dependent upon availability of active membrane receptor pools, the impaired response to 
D-fenfluramine in recuperated animals is likely a consequence of the reduced 5-HT2CR protein 
expression in the hypothalamus of these animals.  
We used LCM of the ARC combined with microarray analysis to identify differentially 
expressed genes that could be affected by early hyperserotonemia. The expression of KHSRP, which 
is involved in the control of mRNA decay (Gherzi et al., 2006; Ruggiero et al., 2007) and plays a key 
role in the translation of DNA damage signalling to miRNA biogenesis (Trabucchi et al., 2009; Zhang 
et al., 2011) was increased in 3-month-old recuperated offspring. Although recuperated animals 
have reduced longevity (Jennings et al., 1999), which is associated with increased oxidative stress 
and an impaired response to DNA damage (Tarry Adkins et al., 2008; Tarry Adkins et al., 2009) the 
functional significance of the increase in KHSRP in the brain of these animals remains to be 
determined. 
5-HT2AR is another gene that was increased in the 3-month-old recuperated offspring. The 
precise role that 5-HT2AR plays in food intake regulation has not been fully defined. 5-HT2AR was up-
regulated in the ARC of diet-induced obese rats (Park et al., 1999), while in humans, 5-HT2AR 
correlated positively with BMI and a polymorphism in the gene encoding 5-HT2AR has been 
associated with obesity (Rosmond et al., 2002; Erritzoe et al., 2009; Carr et al., 2013). However, 
knockout of 5-HT2AR in mice does not alter food consumption or body weight gain when mice are fed 
laboratory chow (Weisstaub et al., 2006), suggesting the presence of developmental compensatory 
mechanisms or that body weight gain only occurs when these mice are placed on an obesogenic 
diet. There is little information regarding the precise neuronal location of 5-HT2AR within the ARC. 
Here we report that 5-HT2ARs, like 5-HT2CRs (Heisler et al., 2002; Lam et al., 2008), are anatomically 
positioned to influence the activity of the critical energy balance regulator POMC.  The extent to 
which the activity of POMC neurons can be influenced by action at 5-HT2ARs and whether this 
mechanism is altered in recuperated offspring as well as direct evidence for linking fetal 
hyperserotonemia to alteration of 5-HT2AR in later life remain to be established. 
As 5-HT2AR expression was increased in the ARC of recuperated pups at weaning and in 
adulthood but not in brains of fetuses or neonates, the differences in 5-HT2AR must be established 
during the period of catch-up growth, between day 3 and day 22 of life, much later then the 
observed differences in 5-HT2CR levels. Therefore, up-regulation of 5-HT2AR may act as a secondary, 
counter-regulatory response to impaired 5-HT2CR signalling. Counter-regulatory mechanisms have 
been reported among 15 existing 5-HT receptor subtypes as genetic alteration of one specific 5-HT 
receptor subtype can result in compensatory signalling via another, for example signalling through 5-
HT1BR in the absence of 5-HT2CR (Heisler and Tecott, 2000; Dalton et al., 2004). It is possible that 
counter-regulatory up-regulation of 5-HT2AR in response to impaired signalling via 5-HT2CR only 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
emerges when growth-restricted newborn pups are born into and exposed postnatally to an 
environment of plentiful food. Some effects of early alterations in 5-HT therefore, may only appear 
in the presence of a particular postnatal environment. This has been shown to be true in a study of 
selective serotonin reuptake inhibitor-exposed 3-month-old infants, showing altered HPA stress 
response patterns which only became apparent when the method of infant feeding was taken into 
consideration (Oberlander et al., 2008).  
5-HT2AR stimulation via agonist administration produced a greater effect on appetite in 
recuperated rats, revealing that the over-expressed ARC 5-HT2ARs are functional. Since 
pharmacological stimulation of endogenous 5-HT was less effective in suppressing appetite in 
recuperated rats, these results suggest that the endogenous circuitry is insufficient to appropriately 
modulate 5-HT-regulated appetite. However, this endogenous programming change may be 
circumvented and the up-regulation of the 5-HT2AR may be capitalized upon through 
pharmacological treatment with a 5-HT2AR non-hallucinogenic agonist. The anorectic therapeutic 
profile could be potentially further improved by combining the 5-HT2AR agonist, with 5-HT2CR and 5-
HT1BR agonists as the co-application of 5-HT2CR and 5-HT1BR agonists produced a significant increase 
in the activity of POMC in the ARC (Doslikova et al., 2013). Development of a non-hallucinogenic 5-
HT2AR agonist may seem to be challenging however, studies showing that the glutamate mGlu2 
receptor heterocomplex with 5-HT2AR, and not 5-HT2AR on its own, acts as a molecular target for the 
actions of hallucinogenic drugs provide a plausible avenue to explore in the development of 
therapeutically suitable5-HT2AR agonist (Moreno et al., 2012). 
Although we concentrated on studying mechanisms that potentially could mediate the 
effects of early elevated 5-HT levels on obesity risk in later life, early perturbations in the 5-HT 
neurotransmitter system are known to have major implications for mental health and behaviour in 
childhood and adulthood. Increased anxiety-like behaviour in nonhuman primate offspring of dams 
fed high fat diet  was associated with perturbations in 5-HT system during fetal life (Sullivan et al., 
2010). Early hyperserotonemia, in particular, has been identified as a potential factor in the 
pathogenesis of Autism Spectrum Disorder and Schizophrenia (Chugani, 2004; Madden and Zup, 
2014). In addition, both 5-HT2AR and 5-HT2CR that are expressed throughout the brain have been 
implicated in the pathophysiology of psychiatric disorders (Abramowski et al., 1995; Hoyer et al., 
1986; Heisler et al., 2007; Mestre et al., 2013; Lyddon et al., 2013]. 5-HT2CRs for example, was shown 
to play a role in addiction and reward behavior via modulating dopamine transmission within the 
mesolimbocortical dopaminergic system (Katsidoni et al., 2011). Dysregulation of the reward-related 
neurotransmitter systems and behaviours could also contribute to the increased susceptibility to 
obesity in the recuperated offspring (Grissom et al., 2014) 
In summary, we report that elevated 5-HT in fetuses exposed to maternal protein 
restriction, may underlie a permanent reduction in 5-HT2CR expression and function and secondary 
counter-regulatory up-regulation of 5-HT2AR and increased sensitivity to 5-HT2AR agonist. Thus, our 
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results not only identify a molecular mechanism through which maternal diet may impair offspring 
energy balance but also point to a promising pharmacological strategy with 5-HT2AR agonist 
medication to correct this impairment. 
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Materials and Methods 
Experimental groups and tissue collection 
All procedures involving animals were conducted in accordance with the University of 
Cambridge and the University of Buckingham project licences under the UK Home Office Animals 
(Scientific Procedures) Act (1986). The breeding of animals was conducted at both the University of 
Cambridge and the University of Buckingham. Five cohorts of Wistar rats (Rattus norvegicus) were 
established for the studies: 1st for E16.5 experimental measures, 2nd for laser-capture 
microdissection (LCM) and microarray validations, 3rd for in situ hybridization, 4th for 
intracerebroventricular (i3v) and 5-HT/tryptophan measurements and 5th for protein and mRNA 
analysis. Detailed information regarding the diet composition and the set-up of the maternal protein 
restricted and control dams have been published previously (Cripps et al., 2009; Berends et al., 
2013). Briefly, on postnatal day 3 (P3) two experimental groups of offspring were established: 
controls [offspring of control dams (20% protein, w/v), culled to eight (four males and four females) 
suckled by control dams] and recuperated [offspring of dams fed a low-protein diet (8% protein, 
w/v) during pregnancy, but nursed by control dams, culled to four males to maximize the plane of 
nutrition]. The animals were allocated to experimental groups at random. Whole heads were 
collected from fetuses at E16.5 of pregnancy and from male pups at P3. In addition hypothalami 
were dissected from brains of male offspring at P3. The body weight of the remaining pups was 
recorded at P7, P14 and P21. Following weaning at day 22, one male per litter was culled by a rising 
concentration of CO2 and the brain was dissected. After weaning, the remaining males were fed 
standard laboratory chow and body weight and food intake were recorded weekly. At 3 months of 
age males were culled and brains were collected. All the dissected brains and heads were frozen on 
powdered dry ice and were stored at -80°C until further processing. Amniotic fluid and placentas 
were harvested at E16.5 and serum was prepared from the dams and male pups at P3, weaning and 
3 months of age, and stored at - 80°C prior to the measurement of 5HT and tryptophan levels.  
 
5-HT and tryptophan assay 
Whole brains, placentas, amniotic fluid and serum were used for measurement of 5-HT (DRG 
International, Inc, New Jersey, USA) and tryptophan (Abnova, Heidelberg, Germany) by ELISA 
following the manufacturer’s recommendation for sample preparation, acylation (5-HT) and 
derivatisation (tryptophan). For the measurement of 5-HT in tissue, hypothalamic blocks were 
excised from frozen brains and extracted as described (Huang et al., 2012). Briefly, samples were 
homogenised and deproteinised for 30 min in 0.2 N perchloric acid solution containing 7.9 mM 
Na2S2O5 and 1.3 mM disodium ethyleneamine-tetra-acetic acid. The homogenate was centrifuged at 
10,000 g for 10 min at 4 0C and the supernatant assayed for 5-HT. 
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Feeding studies 
Animals were cannulated as described previously (Stocker et al., 2012). Briefly a cannula was 
inserted into the third ventricle under a gaseous anaesthetic (isofluorane: Isoba, Schering-Plough 
Animal Health) using coordinates from the stereotactic rat brain atlas (Paxinos and Watson, 1998). 
Its position was verified by a positive drinking response over 15 min to angiotensin II (20 gml-1 in 
2.5 l). For measurements of acute effects of D-fenfluramine or 5-HT2AR agonism on food intake, 3-
month-old rats were individually housed, fasted for 4 h, dosed at the beginning of the dark period 
and re-fed. Peptide (250 nmoles) was given in 2.5 l saline. Animals were dosed using a Latin square 
design. Doses were separated by at least 4 days and normal feeding behaviour and body weight was 
restored prior to administration of the next dose. The specificity and doses of the D-fenfluramine 
(Tocris Bioscience, Bristol, UK), or the high affinity 5-HT2AR receptor agonist TCB-2 (Tocris 
Biosciences, Bristol, UK) were based on published data (Vickers et al., 1999; Vickers et al., 2001; 
Trifunovic and Reilly, 2006; McLean et al., 2006; Xu et al., 2010, Fox et al., 2010) and doses were 
optimised by ourselves.  
 
 Western blotting 
Hypothalami were dissected from frozen brains according to landmarks: anterior to the optic 
chiasma; posterior to the mammillary bodies; lateral at the hypothalamic sulcus; and superior to the 
anterior commissure. Dissected hypothalami from day-3 and 3-month-old male offspring were 
homogenised in TK lysis buffer and Western blotting analysis was carried out as previously described 
(Martin-Gronert et al., 2008). Anti-goat primary antibody against 5-HT2CR was purchased from Santa 
Cruz Biotechnology (cat sc-15081, lot D1114, Santa Cruz, USA) and 1:200 dilution was used. The 
antibody was validated in two previous studies (Bubar et al., 2005; Anastasio et al., 2010). 
Horseradish peroxidase-conjugated secondary antibody [anti-goat antibody (Jackson 
ImmunoResearch, Stratech, Newmarket, UK)] was used at 1:10000 dilution. 
 
Laser-capture microdissection (LCM), RNA isolation and analysis 
Hypothalamic sections of the ARC were prepared on a cryostat at 14m thickness from 
approximately -4.52 to -2.30 mm relative to Bregma (Paxinos and Watson, 1998). Sections were 
collected onto RNase-free membrane-coated slides (P.A.L.M) that had been baked at 200oC for 4 hrs 
and UV cross-linked for 30 min. Within 24 hours of sectioning, sections were placed for 30 s each 
time in 95%, 75% and 50% ethanol for rehydration. Sections were stained with 1% cresyl violet stain 
(Ambion) for 1 min, dehydrated in graded ethanol concentrations (50%, 75% and twice in 100% for 
30 s each time), placed in HistoClear (National Diagnostics) for 5 min and air dried. LCM was 
performed using a P.A.L.M. MicrolaserSystem (P.A.L.M. Microlaser Technologies) (Figure 4A). 
Following microdissection, the captured cells were kept in RNAlater (Ambion). Total RNA was 
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isolated from LCM samples using the RNAqueous Micro RNA extraction kit (Ambion) in accordance 
with the manufacturer’s protocol. The quality and quantity of the RNA samples was determined 
using Agilent BioAnalyzer PicoChips (Agilent Technologies Inc, Santa Clara, CA, USA). Total RNA was 
isolated from E16.5 fetal heads and neonatal and adult (3 months of age) hypothalami as previously 
described (Zaibi et al., 2010) and analyzed using a NanoDrop ND1000 (Thermo Fisher Scientific, 
Delaware, USA).  
 
RNA amplification  
An ovation Pico RNA Amplification System (Nugen Technologies Inc, San Carlos, CA, USA) 
was used for the amplification of RNA destined for microarray analysis. RNA amplification of LCM 
ARC samples used to validate genes identified by microarray analysis was performed using a 
MegaScript T7 Amplification Kit (Ambion) in combination with the GeneChip sample CleanUp 
Module kit (Affymetrix). The use of a different method of RNA amplification enhanced the validation 
of the microarray data. 
 
Microarray hybridization 
The amplified RNA was used for gene expression profiling on Affymetrix Rat Genome 230 2.0 
Arrays (Affymetrix Inc, San Carlos, CA, USA) using the Affymetrix GeneChip protocol to fragment and 
label the target, ready for hybridization to the arrays (Affymetrix 2004). GeneChip sequences were 
selected from GenBank, dbEST and RefSeq and the sequence clusters created using UniGene were 
then further refined by comparison with the publicly available assembly of the rat genome. 
Microarray hybridization was carried out by Molecular Biology Services at the University of Warwick, 
using n=6 chips per group. 
 
Microarray analysis and selection of the genes for validation 
Raw image data files were converted to CEL and pivot files using Affymetrix GeneChip 
Operating Software. All downstream analysis of microarray data was performed using GeneSpring 
GX 12.0 (Agilent). The CEL files were used for the RMA (Irizzarry et al., 2003) and GC-RMA (Wu et al., 
2004) analyses, while the pivot files were used for GCOS analysis. After importing the data, each chip 
was normalized to the 50th centile of the measurement taken from that chip and all gene expression 
data reported as a fold-change from the control state. Genes were considered to be up- or down-
regulated if the 1.3-fold threshold was reached and P<0.05. Only genes that met the above criteria 
using three different algorithms: GCOS, RMA and GCRMA were taken forward for additional study. 
The further selection of genes for validation was based on the function of the gene and the 
availability of suitable primers for validation. Functional analysis was performed using Ingenuity 
Pathway Analysis (Ingenuity Systems Inc).  
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Validation of microarray data using Taqman RT-PCR  
Validation of the microarray data was carried out using Micro Fluidic Cards (Applied 
Biosystems, Foster City, CA, USA) in accordance with the manufacturer’s protocol (Applied 
Biosystems). The reactions were performed in duplicate for each sample using an ABI 7900HT 
(Applied Biosystems).  A standard curve was constructed for each gene using a serial dilution of 
pooled cDNA from all LCM ARC samples. The mean CT values of the experimental samples were then 
used to calculate the relative expression for each sample. The data was normalized to Ppia 
(cyclophilin) expression which did not change between maternal treatment groups. Real time PCR 
(StepOneTM, Applied Biosystems, Paisley, UK) was carried out using Assay-on-Demand pre-designed 
primer and probe sets (Applied Biosystems, Paisley, UK). Data were analyzed using the comparative 
ΔCt method, comparing recuperated animals with controls. All procedures were carried out in 
accordance to the manufacturer’s recommendation.  
 
In Situ Hybridization Histochemistry (ISHH) 
Coronal sections (20 m) of frozen hypothalamic ARC, obtained using a cryostat, were thaw-
mounted onto poly-L-lysine slides (Polysine, Menzel Glaser, Braunschweig, Germany). Ten sets of 
slides per animal were serially collected, with the first set of 10 beginning at approximately -4.52 and 
ending at -2.12 mm, relative to Bregma, according to the atlas of the rat brain (Paxinos and Watson). 
For the sectioning of neonatal rat brains whole heads were used and the sectioning was guided by 
the neonatal rat brain atlas (Ramachandra and Subramanian, 2011).  Slides were stored at –80 C 
until use. 
A [35S]-radiolabelled riboprobe targeting nucleotides 1700-1910 of the rat 5-HT2AR mRNA 
transcript was generated by PCR from whole rat brain cDNA. The 210 bp fragment was cloned into 
pCR-TOPO4 (Life Technologies, Paisley, UK). For antisense probe generation, Pst1 linearised 
recombinant plasmid was subjected to in vitro transcription using T7 polymerase in the presence of 
35S-labelled UTP, as per manufacturer’s instructions (Ambion). The ISHH procedure used has been 
described in detail previously (Alon et al., 2009; Garfield et al., 2012). Autoradiographic images were 
quantified using Image Proplus software (Media Cybernetics, MD 20910). Standard curves were 
generated from 14C autoradiographic microscales (Amersham, UK) and integrated optical density 
(IOD) and area of the hybridization signal were measured. For each animal, 3-5 sections of ARC (-
4.52mm to -2.12 mm from bregma) and 2-3 sections for VMN (-3.60mm to -2.12mm from bregma) 
were analyzed. Average ARC and VMH 5-HT2AR mRNA expression was calculated.  
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Dual-label ISHH and immunohistochemistry (IHC) 
To assess co-localisation of 5-HT2AR and POMC, brains taken from control rats, were first 
processed for detection of 5-HT2AR mRNA by ISHH, as described above. Following this, the tissue was 
washed in PBS before commencement of the IHC protocol to label α-melanocyte-stimulating 
hormone (MSH) protein using procedures previously described (Alon et al., 2009; Garfield et al., 
2012). Briefly, sections were incubated in 0.3% H2O2 in PBS, then rinsed in PBS, blocked in 0.5% BSA/ 
0.5% Triton-X 100 in PBS and left in blocking buffer containing rabbit α-MSH antibody (1/10,000; 
Chemicon, Millipore, MA, USA) overnight. Tissue was then washed in PBS and a biotinylated donkey 
anti-rabbit secondary antibody (Vector Laboratories, CA, USA) was applied at 1/1000 in blocking 
buffer. Sections were then washed in PBS, incubated in VectaStain ABC reagent, and following this, 
chromogenic detection was conducted using 3,3'-diaminobenzidine (DAB) reagent (Vector 
Laboratories). Sections were mounted onto superfrost slides, dried, then dipped in photographic 
emulsion (Kodak) and stored at 4°C for two weeks before being developed using Kodak developer 
and fixer. Double labelled cells were recorded if α-MSH-immunoreactive (IR) positive cell bodies 
were overlaid with a 35S 5-HT2AR signal greater than 3X background. 
 
Statistical analysis 
 Two-tailed unpaired Student’s t-test was used for statistical analysis and the data are 
presented as mean±s.e.m. unless otherwise stated. Fractional growth rates were calculated using 
formula: fractional growth rate = (current - starting weight)/(period x starting weight). For 
microarray data p-values were calculated using a two-tailed t-test. All data were analyzed using 
GraphPad Prism (Graphpad, La Jolla, USA). Number (n) refers to number of litters used. P<0.05 was 
considered statistically significant.  
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Data availability 
GSE76012 study at: 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76012 
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Figure 1.  Effects of maternal protein restriction on 5-HT levels in pregnant rat dams. (A) 5-HT 
levels in maternal serum, the placenta, fetal brain (all analyzed at E16.5) and neonatal 
hypothalamus. Data analyzed using unpaired Student’s t test and presented as % mean control, for 
maternal serum 5-HT n=6, placenta 5-HT n=16, fetal brain 5-HT n=10, neonatal hypothalamus n=12 
per group. (B, C) Correlations between maternal, placental and fetal 5-HT levels. (B) Correlation 
between placental 5-HT and maternal serum tryptophan, analyzed using Pearson correlation 
coefficient as data was normally distributed, n=6 per group. (C) Correlation between placental 5-HT 
and fetal head 5-HT analyzed using Spearman correlation coefficient as data was not normally 
distributed. n=10 per group, n represents number of litters. * P<0.05; ** P<0.01. 
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Figure 2. Effects of maternal protein restriction on food intake in 3-month-old offspring following 
central administration of D-fenfluramine (Dex). Food consumption during the 2 hours following 
lights out expressed as a percentage of the saline dosed group. Difference between the groups 
analyzed by one-way ANOVA to saline for control and recuperated offspring. n=6 per group with n 
representing number of litters. The following numbers of animals were used for each experimental 
group: control saline =18 rats, control Dex =20, Recuperated saline =17 and Recuperated Dex =20 
rats. D-fenfluramine was administered at the dose of 250 nmoles in 2.5 ul of saline. * P<0.05 for 
Control Dex versus Recuperated Dex. *** P<0.001 for Control saline versus Control Dex. 
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Figure 3. Effects of maternal protein restriction on central 5-HT2CR mRNA and protein expression in 
the offspring.  (A) 5-HT2CR mRNA levels as measured using qRT-PCR. Gene expression data was 
normalized to Ppia. (B) 5-HT2CR protein levels analyzed using Western blotting. (C) Western blots. 20 
mg and 10 mg of pooled samples were loaded in the middle of the gels to ensure the linearity of the 
signal. Data analyzed using unpaired Student’s t test and presented as % mean control±s.e.m. n=8 
per group, n represents number of litters * P<0.05; *** P<0.001. 
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Figure 4. Laser-capture microdissection (LCM) of the hypothalamic ARC of 3-month-old rats and 
microarray analysis results.  (A) LCM of the ARC (-4.52 to – 2.30 mm relative to Bregma). Brain Atlas 
image was taken from Paxinos and Watson (1998). (B, C) Venn diagrams showing the effects of 
maternal protein restriction followed by catch up growth on the expression of genes in the ARC of 
male 3-month-old offspring, according to three different, robust analyses: GeneChip Operating 
Software (GCOS), GeneChip Robust Multi-array Averaging (GC-RMA) and Robust Multi-array 
Averaging (RMA). Genes were considered to be up- or down-regulated if the 1.3-fold threshold was 
reached and P<0.05. (B) Up-regulated genes and (C) Down-regulated genes in the recuperated 
animals when compared to controls. The sizes of circles and numbers in parentheses indicate the 
number of genes as identified by either the GCOS, RMA or GC-RMA algorithms. For microarray 
analysis n=6 chips per group, n represents number of litters. 
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Figure 5. Validation of the differentially expressed genes identified using microarray approach as 
being regulated by early nutrition. (A) Validation of the differentially expressed genes in the ARC of 
3-month-old control and recuperated offspring. Analysis carried out using Taqman qRT-PCR. Gene 
expression data was normalized to Ppia. Data analyzed using a two-tailed unpaired Student’s t-test. 
(B) Validation of 5-HT2AR mRNA expression in the ARC using ISHH. (C) 5-HT2AR mRNA expression in 
rats at 3 and 22 days of age in the ARC. (D) 5-HT2AR mRNA expression in 3-month-old rats in the 
VMN using ISHH. (E) 5-HT2AR mRNA expression in 3 and 22 day old rats in the VMN. (F) Localisation 
of 5-HT2AR on ARC POMC neurons in 3-month-old Control rats as detected using ISHH for 35S-5-HT2AR 
and chromogenic IHC for α-MSH. Dense black granular staining directly overlapping brown α-MSH 
cell body and axons indicates the presence of 5-HT2AR on POMC neurons. Scale bar for ARC image 
represents 200 m, in the inset 10 m. for (B, D) Data were analyzed using two-tailed Student t-test, 
for (C, E) A two-way ANOVA was used with appropriate Duncan’s posthoc test. Values are expressed 
as means±s.e.m. For (A, B, D) n=8 per group, for (C, E) n=6-8 per group, n represents number of 
litters. * P<0.05; ** P<0.01. 
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Figure 6. Effects of maternal protein restriction on food intake following central administration of 
the 5-HT2AR agonist (TCB2) in 3-month-old rats. Food consumption during the 2 hours following 
lights out expressed as a percentage of the saline dosed group. Differences between the groups 
were analyzed using two-way ANOVA (overall effect of TCB2 administration, P<0.001; overall effect 
of early nutrition, P<0.05) followed by Bonferroni’s multiple comparison test. n= 13-15 per group, n 
represents number of litters. * P<0.05 
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Table 1. Growth trajectories, body weights and brain weights 
A. Growth trajectory during postnatal life 
 
 
 
 
 
B. Body and brain weights after weaning 
 
 
 
 
 
 
 
 
 
  
Data analyzed using Student’s t test. Values are expressed as means±s.e.m. n =10 per group, * P<0.05; *** 
<0.001  
 
 
 
  
Body weight (g) Control Recuperated 
P3         7.4 ± 0.3      6.2 ± 0.2*** 
P7       15.9 ± 0.8    13.4 ± 1.1* 
P14       32.0 ± 1.1    32.5 ± 1.4 
P21       52.2 ± 1.4    55.5 ± 1.4 
        Control   Recuperated 
Body weight (g) at 3M        417 ± 9.0         417 ± 7.9  
Brain weight (g) at P22       1.33 ± 0.11             1.42 ± 0.02        
Brain weight (% of BW) at P22       2.90 ± 0.08        2.77 ± 0.08 
Brain weight (g) at 3M       2.00 ± 0.03             1.97 ± 0.05        
Brain weight (% of BW) at 3M       0.48 ± 0.01        0.47 ± 0.01 
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Table 2. Genes in the ARC that are differentially expressed between the recuperated and control 
3-month-old male rats 
 
(A) Top 25 genes increased in Recuperated offspring compared to Controls  
 
 
  
Probe Set ID Fold 
Change 
Gene Symbol Gene Title 
1387752_at 2.55 Htr2a 5-hydroxytryptamine (serotonin) receptor 2A 
1379905_at 1.91 Gtpbp1 GTP binding protein 1 
1377472_at 1.78 Extl1 exostoses (multiple)-like 1 
1389755_at 1.71 Cdca7l cell division cycle associated 7 like 
1376525_at 1.69 Khsrp KH-type splicing regulatory protein 
1393134_at 1.69 Sephs1 selenophosphate synthetase 1 
1394434_at 1.68 Snf1lk2 SNF1-like kinase 2 
1383843_at 1.66 Hlcs holocarboxylase synthetase  
1377726_at 1.59 Trim25 tripartite motif-containing 25 
1381410_at 1.58 Fgd5 FYVE, RhoGEF and PH domain containing 5 
1383606_at 1.56 Tc2n tandem C2 domains, nuclear 
1379817_at 1.53 Purg purine-rich element binding protein G 
1371356_at 1.51 Tenc1 tensin like C1 domain containing phosphatase (tensin 2) 
1370806_at 1.51 Retsat retinol saturase (all trans retinol 13,14 reductase) 
1378776_at 1.50 Pou6f1 POU class 6 homeobox 1 
1395261_at 1.49 Snrp70 U1 small nuclear ribonucleoprotein polypeptide A 
1369601_at 1.49 Nyw1 ischemia related factor NYW-1 
1381919_at 1.48 Hps6 Hermansky-Pudlak syndrome 6 
1396053_at 1.47 Nedd9 neural precursor cell expressed 
1378282_at 1.47 Csnk2a2 casein kinase 2, alpha prime polypeptide 
1389632_at 1.46 Rhobtb1 Rho-related BTB domain containing 1 
1368561_at 1.45 Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 
1393320_at 1.45 Utp15 UTP15, U3 small nucleolar ribonucleoprotein 
1390506_at 1.44 Med1 mediator complex subunit 1 
1376423_at 1.44 Fbxl19 F-box and leucine-rich repeat protein 19 
1376565_at 1.33 Pde4a Phosphodiesterase 4A 
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(B) Top 25 genes decreased in Recuperated offspring compared to Controls  
Probe Set ID Fold 
Change 
Gene Symbol Gene Title 
1387675_at 2.48 Plau plasminogen activator, urokinase 
1382284_at 2.09 Nek3 NIMA (never in mitosis gene a)-related kinase 3 
1384767_at 1.80 Usp42 ubiquitin specific peptidase 42 
1375362_at 1.74 Sppl2a signal peptide peptidase-like 2A 
1372995_at 1.70 Prkd2 protein kinase D2 
1398431_at 1.67 Car8 carbonic anhydrase 8 
1371770_at 1.63 RT1-CE4A2 prefoldin 6 
1369638_at 1.62 Eef2k eukaryotic elongation factor-2 kinase 
1370204_at 1.59 Frag1 FGF receptor activating protein 1 
1396268_at 1.58 Sp110 SP110 nuclear body protein 
1391669_at 1.57 Ptprb protein tyrosine phosphatase, receptor type, B 
1385871_at 1.54 Dhx36 DEAH (Asp-Glu-Ala-His) box polypeptide 36 
1388030_at 1.48 RT1-M6-1 gamma-aminobutyric acid (GABA) B receptor 1 
1392174_at 1.47 Chst12 carbohydrate sulfotransferase 12 
1376644_at 1.46 Med19 mediator complex subunit 19 
1388705_at 1.44 RGD1565037 selenoprotein M 
1389123_at 1.44 Ccl6 chemokine (C-C motif) ligand 6 
1370384_at 1.43 Prlr prolactin receptor 
1372270_at 1.43 Dpagt1 GlcNAc-1-P transferase 
1373109_at 1.43 Map2k7 mitogen activated protein kinase kinase 7 
1375137_at 1.38 Arpc2 actin related protein 2/3 complex, subunit 2 
1393172_at 1.35 Nab1 Ngfi-A binding protein 1 
1388088_at 1.34 Usf2 upstream transcription factor 2 
1397642_at 1.34 Rad50 RAD50 homolog (S. cerevisiae) 
1398242_at 1.34 Ppp5c Protein phosphatase 5, catalytic subunit 
 
(C) RMA Plier gene function analysis for Recuperated offspring compared to Controls  
Category p value 
Cell Cycle 7.01E-05 
Connective Tissue Development and Function 7.01E-05 
Cellular Growth and Proliferation 1.64E-04 
Drug Metabolism 1.64E-04 
Molecular Transport 1.64E-04 
Small Molecule Biochemistry 1.64E-04 
Cancer 1.65E-04 
Neurological Disease 2.34E-04 
Cellular Development 3.55E-04 
Cellular Assembly and Organization 4.88E-04 
 
Fold-changes were calculated by comparison of the mean expression value in the 3-month old 
recuperated offspring to the age-matched control group. P<0.05 for all the genes identified. 
 
